To test whether the gene expression of one of the several transcription variants of CDKN2A, p14ARF reflects ccRCC-associated changes, we determined and compared the normalised mRNA levels of each normal and tumour sample. This evidence concerns the gene CDKN2A and nonpapillary renal cell carcinoma.